INO • NASDAQ
Inovio Pharmaceuticals Inc
$1.89
After Hours:
$1.88
(0.53%)-0.0100
Closed: Jul 1, 7:57:02 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$1.73
Day range
$1.72 - $1.89
Year range
$1.38 - $9.96
Market cap
432.89M USD
Avg Volume
7.86M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Financial performance
Revenue
Net income
(USD)Mar 2022Y/Y change
Revenue
199.07K-46.36%
Operating expense
15.95M14.93%
Net income
-79.07M-45.35%
Earnings per share
-0.36-33.33%
EBITDA
-70.68M-36.56%
Effective tax rate
Financial performance
Total assets
Total liabilities
(USD)Mar 2022Y/Y change
Cash and short-term investments
360.39M-30.51%
Total assets
445.51M-31.97%
Total liabilities
90.43M23.44%
Total equity
355.09M
Shares outstanding
229.04M
Price to book
1.10
Return on assets
-38.10%
Return on capital
-43.66%
Financial performance
Net change in cash
(USD)Mar 2022Y/Y change
Net income
-79.07M-45.35%
Cash from operations
-61.88M-17.05%
Cash from investing
21.33M107.75%
Cash from financing
28.42M-82.34%
Net change in cash
-12.13M92.74%
Free cash flow
-34.78M-4.61%
About
Inovio Pharmaceuticals is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Founded
1999
Website
Employees
317
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for